NeurologyOnline.net

Neurology Xagena

Search results for "Copaxone"

Clinical research data, published in the journal Multiple Sclerosis, provided evidence that Copaxone ( Glatiramer ) may offer protection from axonal injury and induced neuronal metabolic recovery in p ...


Adding Salbutamol ( Albuterol; Ventolin ), a compound commonly used to treat asthma and other respiratory diseases, to an existing treatment for patients with multiple sclerosis appears to improve cli ...


The results from the Lemtrada ( Alemtuzumab ) CARE-MS I and CARE-MS II pivotal studies in patients with relapsing-remitting multiple sclerosis were published in The Lancet.In CARE-MS I and CARE-MS II, ...


Data from the phase III GALA ( Glatiramer Acetate Low-Frequency Administration ) trial were presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis ( ...


In patients with relapsing–remitting multiple sclerosis ( RRMS ), a scoring system based on new magnetic resonance imaging ( MRI ) active lesions, relapses and sustained disability progression after a ...


Five-year results from the ENDORSE phase 3 extension study have shown Dimethyl fumarate ( Tecfidera ) provides strong and sustained efficacy in a broad range of people living with relapsing-remitting ...